Stockreport

Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines [Yahoo! Finance]

Nuvectis Pharma, Inc.  (NVCT) 
PDF Single Agent Antiproliferative Activity in Cells Resistant to Alectinib, the Active Ingredient in Alecensa TM Fort Lee, NJ, April 08, 2024 (GLOBE NEWSWIRE) -- Nuvecti [Read more]